AbbVie
ABBV
$351.22
Share price
-3.74%
Change (1 day)
17.84%
Change (1 year)
Categories
The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
Earnings for AbbVie (ABBV)
Earnings in 2024 (TTM): NZ$5.72 Billion
According to AbbVie's latest financial reports the company's current earnings are NZ$56.33 Billion. a decrease over its 2023 earnings that were of NZ$10.90 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for AbbVie from 2011 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | NZ$6.48 B | -40.54% |
| 2023 | NZ$10.90 B | -53.62% |
| 2022 | NZ$23.50 B | 3.76% |
| 2021 | NZ$22.65 B | 282.25% |
| 2020 | NZ$5.92 B | -59.67% |
| 2019 | NZ$14.69 B | 62.13% |
| 2018 | NZ$9.06 B | -32.74% |
| 2017 | NZ$13.47 B | -1.99% |
| 2016 | NZ$13.75 B | 18.65% |
| 2015 | NZ$11.59 B | 180.5% |
| 2014 | NZ$4.13 B | -55.57% |
| 2013 | NZ$9.30 B | -6.86% |
| 2012 | NZ$9.98 B | 56.05% |
| 2011 | NZ$6.39 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | NZ$19.38 B | 199.06% | 🇺🇸 USA |
 | -NZ$14.62 Billion | -325.48% | 🇺🇸 USA |
 | NZ$22.11 B | 241.24% | 🇺🇸 USA |
 | NZ$8.03 B | 24.03% | 🇺🇸 USA |
 | NZ$1.20 B | -81.43% | 🇺🇸 USA |
 | NZ$3.32 B | -48.71% | 🇺🇸 USA |
 | NZ$7.66 B | 18.26% | 🇬🇧 UK |
 | NZ$18.19 B | 180.76% | 🇬🇧 UK |
 | NZ$0.89 B | -86.19% | 🇺🇸 USA |